Serial Number
50063057
Owner
Subsense, Inc.Attorney
SHAILENDRA K MAHESHWARIFiling Date
Aug 20, 2026
NANOBCI Trademark
Serial Number: 50063057
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
SHAILENDRA K MAHESHWARI SELF
12322 Pissaro Drive
N. Potomac, MD 20878
United States
Trademark Details
Filing Date
August 20, 2026
Registration Date
Not Registered
Goods & Services
Software as a service (SaaS) services, including design and development, featuring non-downloadable software for use with brain-computer interface (BCI) devices and systems, enabling non-invasive neural activity stimulation and recording, signal capture and transmission, thought-controlled digital device interaction, enhanced human-machine integration, real-time brain activity monitoring, cognitive function enhancement, cognitive rehabilitation therapies, and improved accessibility for individuals with physical limitations; Research and development services in the field of brain-computer interfaces and biocompatible nanoparticle technology for enhancing human cognition and interaction with technology; Providing technology-based services and consultation, namely, development of technologies utilizing brain-computer interface (BCI) systems for real-time neural activity monitoring, aiding in the early detection and diagnosis of neurological conditions
Biocompatible plasmonic and magnetoelectric nanoparticles for use in brain-computer interface (BCI) systems, for integration with human brain tissue to enable non-invasive stimulation and recording of neural activity, and for real-time diagnostics for enhanced neurological treatments.
Medical devices featuring non-surgical, biocompatible nanoparticles for the treatment of neurological and neurodegenerative diseases through targeted brain stimulation; Brain-computer interface devices for medical use, designed to restore motor functions and enhance cognitive rehabilitation therapies; Health monitoring devices utilizing brain-computer interface (BCI) technology for real-time brain activity analysis and diagnostics, aiding in the treatment and understanding of neurological disorders; Medical devices for providing neurofeedback and biofeedback, supporting therapeutic interventions and cognitive enhancement.